KENNEDY CAPITAL MANAGEMENT LLC
Position in ALDX — Aldeyra Therapeutics, Inc.
CIK 884589
ST LOUIS, MO
Position in ALDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$208,156
+$46,150 QoQ
Shares Held
97,726
+1.9% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 108 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $451,584,893 across 62 Biotechnology names. ALDX ranks #60 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
544,994 | $42,656,680 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
193,215 | $21,452,661 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
724,508 | $17,576,564 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
201,979 | $17,562,074 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
134,019 | $16,428,049 | |
| 6 | MGTX |
MeiraGTx Holdings plc
|
1,105,421 | $14,934,237 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,755,152 | $14,690,622 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
421,374 | $14,280,364 |
All Filings in ALDX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $208,156 | 97,726 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $162,006 | 95,862 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,505,240 | 1,255,838 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,805,751 | 1,112,213 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,631,087 | 686,968 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,092,130 | 1,233,414 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,327,909 | 1,468,519 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,139,010 | 1,881,078 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,294,917 | 1,599,673 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,310,366 | 1,318,155 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,479,272 | 1,276,146 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||